Skip to main content

Table 1 Kaplan-Meier analysis of 41 clinical GBM patients

From: RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway

Clinicopathologic variables Number Average survival time P value
All cases 41 16.475 ± 2.600  
Age at diagnosis (years)    0.382
 <55 19 12.888 ± 1.908  
  ≥ 55 22 20.189 ± 4.422  
Gender    0.618
 Male 22 18.556 ± 4.335  
 Female 19 14.289 ± 2.814  
KPS    0.736
  ≤ 70 8 15.000 ± 4.979  
 >70 33 17.698 ± 3.306  
Headache    0.904
 Yes 18 12.752 ± 1.692  
 No 23 17.195 ± 3.676  
Intracranial infection    0.052
 Yes 3 6.000 ± 4.041  
 No 38 17.352 ± 2.759  
Multiple lesions    0.746
 1 33 16.708 ± 2.740  
  ≥ 2 8 10.250 ± 1.980  
Volume    0.192
  ≥ 42 20 12.075 ± 2.216  
 <42 21 19.473 ± 4.138  
Lobe lesions    0.584
 1 33 15.996 ± 2.907  
  ≥ 2 8 17.469 ± 4.948  
Course time(d)    0.151
  ≥ 30 14 10.399 ± 1.738  
 <30 27 18.820 ± 3.488  
RND2 expression    
 High 20 9.307 ± 1.189 0.017*
 Low 21 21.296 ± 3.981